Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

  • Price (GBX)674.00
  • Today's Change2.00 / 0.30%
  • Shares traded40.64k
  • 1 Year change12.15%
  • Beta0.1885
Data delayed at least 15 minutes, as of Oct 04 2024 16:35 BST.
More ▼

Profile data is unavailable for this security.

About the company

International Biotechnology Trust plc is a United Kingdom-based investment trust company. The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company seeks to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with suitably experienced management and strong potential upside through the development and/or commercialization of a product, device or enabling technology. The Company’s investments may also be made in related sectors, such as medical devices and healthcare services. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. SV Health Managers LLP is the Company's alternative investment fund manager (AIFM).

  • Revenue in GBP (TTM)25.80m
  • Net income in GBP18.19m
  • Incorporated1994
  • Employees0.00
  • Location
    International Biotechnology Trust6th Floor, 65 Gresham Street,LONDON EC2V 7NQUnited KingdomGBR
  • Phone+44 20 7421 7070
  • Websitehttps://ibtplc.com/
More ▼

Profile

Management group(s)Schroder Unit Trusts Limited
AIC sectorBiotechnology & Healthcare
ISINGB0004559349
Launch date06 May 1994
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

The objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. The company invests in companies that are considered to be good value with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

Managed by

Ailsa Craig, Marek Poszepczynski

Management & contract fees

Management fee payable monthly at the rate of 0.7% p.a. of the NAV. The performance fee on the unquoted pool is 20% of net realised gain; performance fee on the quoted pool is 10% of relative outperformance above the sterling-adjusted NBI plus a 0.5% hurdle. Investment Management Agreement is terminable by either party on 12 months’ written notice.

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Jpmorgan China Growth & Income PLC-90.82m-95.92m222.15m0.00222.15m0.00
TwentyFour Select Monthly Income Fnd Ltd40.25m37.93m223.19m0.00223.19m0.00
INVESCO Asia Trust plc9.84m5.56m227.24m0.00227.24m0.00
British Smaller Companies VCT plc14.57m10.62m235.48m0.00235.48m0.00
Martin Currie Global Portfolio Trust PLC18.46m15.85m236.70m0.00236.70m0.00
Blackstone Loan Financing Ltd86.78m85.58m241.29m0.00241.29m0.00
abrdn European Logistics Income PLC33.77m-55.66m247.04m0.00247.04m0.00
International Biotechnology Trust Plc25.80m18.19m247.05m0.00247.05m0.00
CC Japan Income and Growth Trust PLC64.60m60.78m248.58m0.00248.58m0.00
JPMorgan US Smaller Co Inv Trust PLC16.87m12.27m254.69m0.00254.69m0.00
Baillie Gifford UK Growth Trust PLC3.41m389.00k254.77m0.00254.77m0.00
Taylor Maritime Investments Ltd-32.41m-40.77m255.47m8.00255.47m8.00
Manchester & London Investment Trust plc126.36m121.16m268.25m0.00268.25m0.00
Intuitive Investments Group PLC824.00k-865.00k271.07m0.00271.07m0.00
Hansa Investment Company Ltd96.05m91.42m271.60m0.00271.60m0.00
Montanaro European Smllr Cmpns Trst PLC18.37m14.63m272.78m0.00272.78m0.00
Data as of Oct 04 2024. Currency figures normalised to International Biotechnology Trust's reporting currency: UK Pound GBX

Institutional shareholders

63.57%Per cent of shares held by top holders
HolderShares% Held
Interactive Investor Services Ltd.as of 31 Aug 20235.34m14.19%
Hargreaves Lansdown Asset Management Ltd.as of 31 Aug 20235.23m13.88%
Legal & General Investment Management Ltd.as of 01 May 20243.03m8.06%
Border to Coast Pensions Partnership Ltd.as of 31 Aug 20232.54m6.73%
Charles Stanley & Co. Ltd. (Investment Management)as of 14 Mar 20241.87m4.97%
Schroder & Co Bank AG (Private Banking)as of 27 May 20241.45m3.86%
Brewin Dolphin Ltd.as of 31 Aug 20231.32m3.51%
West Yorkshire Pension Fundas of 31 Aug 20231.25m3.31%
South Yorkshire Pensions Authorityas of 24 Jul 20241.06m2.81%
Rathbones Investment Management Ltd.as of 01 May 2024852.00k2.26%
More ▼
Data from 31 Jul 2023 - 05 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.